XNAS · Healthcare · Medical Devices
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | Q1 2026 | 0.33 | 0.25 | -24.24% | $82.0M | ❌ Miss | -0.21% | +3.31% | — |
| 2026-02-10 | Q4 2025 | 0.43 | 0.46 | +6.98% | $103.9M | ✅ Beat | +0.26% | -0.96% | -12.72% |
| 2025-11-05 |
| Q3 2025 |
| 0.32 |
| 0.38 |
| +18.75% |
| $93.2M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-07-30 | Q2 2025 | 0.40 | 0.47 | +17.50% | $95.6M | ✅ Beat | +2.73% | +0.58% | +7.48% |
| 2025-04-28 | Q1 2025 | 0.35 | 0.31 | — | $77.9M | ❌ Miss | +1.12% | -0.07% | +0.91% |
| 2025-02-04 | Q4 2024 | 0.50 | 0.42 | -16.00% | $97.9M | ❌ Miss | +2.63% | +6.17% | +10.34% |
| 2024-08-01 | Q2 2024 | 0.48 | 0.34 | -29.17% | $86.4M | ❌ Miss | +3.56% | +1.27% | -5.13% |
| 2024-05-02 | Q1 2024 | 0.44 | 0.32 | -27.27% | $80.3M | ❌ Miss | +1.61% | +5.76% | +10.89% |
Showing last 8 quarters.